John David Finley - 12 Jun 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
CEO, CFO, Director, Director
Signature
/s/ JD Finley
Issuer symbol
PALI
Transactions as of
12 Jun 2023
Net transactions value
-$1,619
Form type
4
Filing time
14 Jun 2023, 18:23:03 UTC
Previous filing
13 Jun 2023
Next filing
06 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +3,475 +90% $0.000000 7,323 12 Jun 2023 Direct F1
transaction PALI Common Stock, par value $0.01 Tax liability $1,619 -1,050 -14% $1.54 6,273 13 Jun 2023 Direct F2
holding PALI Common Stock, par value $0.01 777 12 Jun 2023 By FCW Investments, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -3,475 -8.3% 38,225 12 Jun 2023 Common Stock 3,475 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
F2 Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units.
F3 Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
F4 This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on June 12, 2023, upon receipt of shareholder approval of the grant, and an additional 38,225 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.